Search

everythinglearnresearchcommunity

for

Search:↓

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Skin issues like hair loss, rash, and sensitivity to sunlight are key signs of lupus activity.

Relatives of lupus patients show signs of immune system activity but not full-blown lupus.

SCAD can indicate ANA-negative lupus, especially in women with unusual symptoms.

A woman with both TLE and SLE improved with hydroxychloroquine treatment.

ANA-negative lupus nephritis can be diagnosed and treated effectively with a comprehensive approach.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Many women with hair loss also have zinc deficiency, iron depletion, or thyroid issues.

Most lab tests for patients with Telogen effluvium, a type of hair loss, show no or mild abnormalities; only a few specific tests are useful.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Doctors should use a detailed patient history and physical exam to diagnose joint pain, and consult a rheumatologist early for suspected autoimmune diseases.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Alopecia areata can be an early sign of Hodgkin’s lymphoma and may improve with lymphoma treatment.

Taking He Shou Wu (Polygonum multiflorum) caused liver injury in a woman using it for hair loss.

People with Chronic Telogen Effluvium mainly have lower iron levels compared to healthy individuals.